Search filters

Filters
Clear All

Phase

  • 7
  • 6
  • 5
  • 10
  • 3
  • 44
  • 83
  • 39
  • 9
  • 74

Found 83 Lymphocytic Leukemia, Acute trials

A listing of Lymphocytic Leukemia, Acute medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

18-39 years
All genders
Phase 3
Interventional
The first purpose of this study is to test the safety of the addition of a drug called inotuzumab to the usual chemotherapy drugs used for adolescent young adults (ages 18-39). Inotuzumab is investigational and is not FDA-approved. Additionally,this study is to compare any good and bad effects of using …
 Antiviral medication to reduce symptoms of COVID-19: A phase 3, placebo-controlled trial

Antiviral medication to reduce symptoms of COVID-19: A phase 3, placebo-controlled trial

18-64 years
All genders
Phase 3
If you tested positive for COVID-19 within the last 5 days, you may be eligible to participate in a research study to test the ability of a pill to reduce COVID-19 symptoms.

Advanced Neuroimaging in Multiple Sclerosis

18-65 years
All genders
MS is a life-long disease that can clinically manifest at a wide range of ages. Lesions in the white matter of the brain can be found at any age in MS patients. How these lesions may affect functioning of the brain is an area we aim to explore. Although connections …

Investigation of Social and Circadian Rhythm Dysregulation in the Development of Depression Symptoms During the Menopause Transition

45-52 years
Healthy Volunteer
Female
The purpose of this study is to examine how depression symptoms develop when women begin the transition to menopause. This study will investigate depression symptoms by looking at how fluctuations in reproductive hormones (specifically, the hormone estradiol) might impact the body's biological sleep rhythms. This study will also look at …

Pilot, Single Center, Feasibility Study of Cuirass Biphasic Ventilator in Chronic Obstructive Pulmonary Disease Patients

21-79 years
All genders
Phase 1
The research study is being conducted to learn about the work of breathing support that an external breathing support device can provide compared to a person’s baseline ability. The research study is sponsored by RightAir Inc, the makers of the device being investigated, the AIR-AD cuirass ventilator. This study is …

Adjustable prosthetic sockets for children and adolescents with lower limb loss to accommodate growth

3-18 years
All genders
Phase 2
This study aims to develop an adjustable, immediate fit prosthetic device for children age 3- 18 which will accommodate growth.  We are looking for children with lower limb amputation- above knee, below knee and symes amputations.All testing will be done within the PM&R Gait Lab  located at 1800 Lombard St, …

Opioid and Brain Study

18-60 years
All genders
Have problem with opiates? You may qualify for the study if you are:    - Between 18–60 years old    - In treatment or seeking treatment for opioid use problems    - Willing to complete one MRI scan of the brain  The study will investigate the psychological and brain mechanisms of opioid use disorder. There will be …
 PROTECT- study of the efficacy and safety of sparsentan for the treatment of Immunoglobulin A (IgAN) nephropathy

PROTECT- study of the efficacy and safety of sparsentan for the treatment of Immunoglobulin A (IgAN) nephropathy

18-99 years
All genders
Phase 3
Immunoglobulin A nephropathy (IgAN) is a rare disease that affects the kidneys, mostly in teens and adults. Kidneys are important to your health because they filter waste materials such as salts, toxins and water out of the blood. The waste is passed out of your body as urine (pee). IgAN …
 Testing the Reward-Drinker Hypothesis of Naltrexone Using an Extended-Release Formulation

Testing the Reward-Drinker Hypothesis of Naltrexone Using an Extended-Release Formulation

18-65 years
All genders
Phase 4
This study is being conducted to compare the effects of a medication (extended-release naltrexone or XR-NTX) or placebo (an inactive substance) together with brief counseling on reducing or stopping drinking.   XR-NTX is approved by the U.S. Food and Drug Administration (FDA) for treating alcohol dependence. Its use is experimental …
 The REMBRANDT Study (Recovery of the Microbiome from Antibiotics for Dental Implants)

The REMBRANDT Study (Recovery of the Microbiome from Antibiotics for Dental Implants)

60-100 years
All genders
The purpose of the study is to determine whether owning a pet changes the disruption and recovery of a person's microbiome (collection of bacteria in the intestines) following a course of antibiotics after they have received dental implant treatment.  
1 - 10 of 83